Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Westermann

Showing results (31-40 of 532) with videos related to

Pageof 54
Sort By:
Heart (British Cardiac Society)|June 22, 2016
Be more sensitive, please - using cardiac troponin assays for diagnosing AMIJohannes Tobias Neumann, Stefan Blankenberg, Dirk Westermann
International Immunopharmacology|January 10, 2008
New perspective on the tissue kallikrein-kinin system in myocardial infarction: role of angiogenesis and cardiac regenerationDirk Westermann, Heinz-Peter Schultheiss, Carsten Tschöpe
European Journal of Heart Failure|September 27, 2017
De-escalation of support with veno-arterial extracorporeal membrane oxygenation and Impella for cardiogenic shock: replyChristian Schulte, Benedikt Schrage, Federico Pappalardo, et al.
Annals of Translational Medicine|October 27, 2018
Beyond conventional secondary prevention in coronary artery disease-what to choose in the era of CANTOS, COMPASS, FOURIER, ODYSSEY and PEGASUS-TIMI 54? A review on contemporary literatureDaniel Kalbacher, Christoph Waldeyer, Stefan Blankenberg, et al.
BMJ Case Reports|September 24, 2014
Fatal recurrence of fulminant giant cell myocarditis and recovery after initialisation of an alternative immunosuppressive regimeNina Fluschnik, Felicitas Escher, Stefan Blankenberg, et al.
ESC Heart Failure|August 4, 2017
Right ventricular temporal assist device for cardiac recompensationIsabell Yan, Hanno Grahn, Stefan Blankenberg, et al.
World Journal of Cardiology|January 6, 2016
Diagnostic and prognostic value of circulating microRNAs in heart failure with preserved and reduced ejection fractionChristian Schulte, Dirk Westermann, Stefan Blankenberg, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|June 5, 2025
The role of cangrelor in acute and high-risk PCI settingsUwe Zeymer, Tobias Geisler, Dirk Westermann, et al.
Biomarkers in Medicine|March 30, 2016
Biomarkers in the triage of chest pain: are we making progress?Johannes Tobias Neumann, Nils Arne Sörensen, Dirk Westermann
Current Pharmaceutical Biotechnology|January 28, 2012
Diastolic heart failure and LV dyssynchronyMario Kasner, Dirk Westermann, Heinz-Peter Schultheiss, et al.
Pageof 54

Showing results (31-40 of 532) with videos related to

Sort By:
Pageof 54
Heart (British Cardiac Society)|June 22, 2016
Be more sensitive, please - using cardiac troponin assays for diagnosing AMIJohannes Tobias Neumann, Stefan Blankenberg, Dirk Westermann
International Immunopharmacology|January 10, 2008
New perspective on the tissue kallikrein-kinin system in myocardial infarction: role of angiogenesis and cardiac regenerationDirk Westermann, Heinz-Peter Schultheiss, Carsten Tschöpe
European Journal of Heart Failure|September 27, 2017
De-escalation of support with veno-arterial extracorporeal membrane oxygenation and Impella for cardiogenic shock: replyChristian Schulte, Benedikt Schrage, Federico Pappalardo, et al.
Annals of Translational Medicine|October 27, 2018
Beyond conventional secondary prevention in coronary artery disease-what to choose in the era of CANTOS, COMPASS, FOURIER, ODYSSEY and PEGASUS-TIMI 54? A review on contemporary literatureDaniel Kalbacher, Christoph Waldeyer, Stefan Blankenberg, et al.
BMJ Case Reports|September 24, 2014
Fatal recurrence of fulminant giant cell myocarditis and recovery after initialisation of an alternative immunosuppressive regimeNina Fluschnik, Felicitas Escher, Stefan Blankenberg, et al.
ESC Heart Failure|August 4, 2017
Right ventricular temporal assist device for cardiac recompensationIsabell Yan, Hanno Grahn, Stefan Blankenberg, et al.
World Journal of Cardiology|January 6, 2016
Diagnostic and prognostic value of circulating microRNAs in heart failure with preserved and reduced ejection fractionChristian Schulte, Dirk Westermann, Stefan Blankenberg, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|June 5, 2025
The role of cangrelor in acute and high-risk PCI settingsUwe Zeymer, Tobias Geisler, Dirk Westermann, et al.
Biomarkers in Medicine|March 30, 2016
Biomarkers in the triage of chest pain: are we making progress?Johannes Tobias Neumann, Nils Arne Sörensen, Dirk Westermann
Current Pharmaceutical Biotechnology|January 28, 2012
Diastolic heart failure and LV dyssynchronyMario Kasner, Dirk Westermann, Heinz-Peter Schultheiss, et al.
Pageof 54